Citigroup’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-329,500
| Closed | -$17.8M | – | 5964 |
|
|
2025
Q4 | $17.8M | Buy |
+329,500
| New | +$15.9M | 0.01% | 1180 |
|
|
2025
Q3 | – | Sell |
-287,700
| Closed | -$13.3M | – | 6097 |
|
|
2025
Q2 | $13.3M | Buy |
287,700
+227,700
| +380% | +$11.2M | 0.01% | 1204 |
|
|
2025
Q1 | $3.66M | Buy |
60,000
+35,000
| +140% | +$2.04M | ﹤0.01% | 2206 |
|
|
2024
Q4 | $1.41M | Hold |
25,000
| – | – | ﹤0.01% | 3085 |
|
|
2024
Q3 | $1.29M | Hold |
25,000
| – | – | ﹤0.01% | 3047 |
|
|
2024
Q2 | $1.04M | Sell |
25,000
-1,000
| -4% | -$44.7K | ﹤0.01% | 2891 |
|
|
2024
Q1 | $1.41M | Sell |
26,000
-213,000
| -89% | -$10.9M | ﹤0.01% | 2744 |
|
|
2023
Q4 | $12.3M | Buy |
239,000
+10,100
| +4% | +$530K | 0.01% | 1117 |
|
|
2023
Q3 | $13.3M | Buy |
228,900
+12,000
| +6% | +$735K | 0.01% | 972 |
|
|
2023
Q2 | $13.9M | Buy |
216,900
+31,500
| +17% | +$2.11M | 0.01% | 981 |
|
|
2023
Q1 | $12.9M | Sell |
185,400
-205,200
| -53% | -$14.5M | 0.01% | 1042 |
|
|
2022
Q4 | $28.1M | Sell |
390,600
-251,600
| -39% | -$19M | 0.02% | 634 |
|
|
2022
Q3 | $45.7M | Buy |
642,200
+428,200
| +200% | +$31.1M | 0.03% | 406 |
|
|
2022
Q2 | $16.5M | Sell |
214,000
-610,800
| -74% | -$46.5M | 0.01% | 891 |
|
|
2022
Q1 | $60.2M | Buy |
824,800
+139,800
| +20% | +$9.39M | 0.04% | 435 |
|
|
2021
Q4 | $42.7M | Buy |
685,000
+169,700
| +33% | +$9.95M | 0.02% | 627 |
|
|
2021
Q3 | $30.5M | Buy |
515,300
+312,800
| +154% | +$20.6M | 0.02% | 762 |
|
|
2021
Q2 | $13.5M | Buy |
202,500
+131,800
| +186% | +$8.59M | 0.01% | 1230 |
|
|
2021
Q1 | $4.46M | Sell |
70,700
-150,500
| -68% | -$9.36M | ﹤0.01% | 1864 |
|
|
2020
Q4 | $13.7M | Sell |
221,200
-138,800
| -39% | -$8.53M | 0.01% | 1306 |
|
|
2020
Q3 | $21.7M | Sell |
360,000
-86,400
| -19% | -$5.2M | 0.01% | 857 |
|
|
2020
Q2 | $26.2M | Sell |
446,400
-742,500
| -62% | -$44.4M | 0.02% | 675 |
|
|
2020
Q1 | $66.3M | Sell |
1,188,900
-423,600
| -26% | -$25.9M | 0.06% | 271 |
|
|
2019
Q4 | $104M | Sell |
1,612,500
-58,700
| -4% | -$3.36M | 0.07% | 246 |
|
|
2019
Q3 | $84.7M | Buy |
1,671,200
+354,300
| +27% | +$16.7M | 0.07% | 281 |
|
|
2019
Q2 | $59.7M | Sell |
1,316,900
-481,200
| -27% | -$22.4M | 0.05% | 368 |
|
|
2019
Q1 | $85.8M | Buy |
1,798,100
+205,800
| +13% | +$10.3M | 0.08% | 224 |
|
|
2018
Q4 | $82.8M | Buy |
1,592,300
+98,900
| +7% | +$5.31M | 0.08% | 229 |
|
|
2018
Q3 | $92.7M | Sell |
1,493,400
-704,000
| -32% | -$41.8M | 0.08% | 209 |
|
|
2018
Q2 | $122M | Buy |
2,197,400
+421,300
| +24% | +$22.8M | 0.11% | 146 |
|
|
2018
Q1 | $112M | Sell |
1,776,100
-170,000
| -9% | -$10.9M | 0.09% | 172 |
|
|
2017
Q4 | $119M | Buy |
1,946,100
+73,500
| +4% | +$4.6M | 0.1% | 193 |
|
|
2017
Q3 | $119M | Buy |
1,872,600
+434,600
| +30% | +$25.4M | 0.1% | 162 |
|
|
2017
Q2 | $80.1M | Sell |
1,438,000
-371,100
| -21% | -$20.2M | 0.07% | 213 |
|
|
2017
Q1 | $98.4M | Buy |
1,809,100
+550,700
| +44% | +$30.2M | 0.09% | 176 |
|
|
2016
Q4 | $73.5M | Buy |
1,258,400
+505,500
| +67% | +$27.6M | 0.07% | 283 |
|
|
2016
Q3 | $40.6M | Buy |
752,900
+439,700
| +140% | +$28.2M | 0.04% | 401 |
|
|
2016
Q2 | $23M | Buy |
313,200
+2,400
| +0.8% | +$170K | 0.02% | 585 |
|
|
2016
Q1 | $19.9M | Sell |
310,800
-150,600
| -33% | -$9.5M | 0.02% | 607 |
|
|
2015
Q4 | $31.7M | Sell |
461,400
-1,588,500
| -77% | -$105M | 0.03% | 527 |
|
|
2015
Q3 | $121M | Buy |
2,049,900
+1,732,500
| +546% | +$110M | 0.11% | 138 |
|
|
2015
Q2 | $21.1M | Sell |
317,400
-27,700
| -8% | -$1.83M | 0.02% | 750 |
|
|
2015
Q1 | $22.3M | Sell |
345,100
-365,200
| -51% | -$22.9M | 0.02% | 716 |
|
|
2014
Q4 | $41.9M | Sell |
710,300
-351,900
| -33% | -$19.8M | 0.04% | 471 |
|
|
2014
Q3 | $54.4M | Buy |
1,062,200
+220,400
| +26% | +$11M | 0.05% | 363 |
|
|
2014
Q2 | $40.8M | Buy |
841,800
+471,500
| +127% | +$23.2M | 0.04% | 423 |
|
|
2014
Q1 | $19.2M | Sell |
370,300
-416,800
| -53% | -$22.2M | 0.02% | 741 |
|
|
2013
Q4 | $41.8M | Sell |
787,100
-88,600
| -10% | -$4.51M | 0.04% | 442 |
|
|
2013
Q3 | $40.5M | Buy |
875,700
+41,500
| +5% | +$1.82M | 0.04% | 433 |
|
|
2013
Q2 | $37.3M | Buy |
+834,200
| New | +$36.2M | 0.04% | 419 |
|
Other funds holding BMY
VCM
VPM
Citigroup's BMY Position: Q1 2026 in Review
Citigroup increased its Bristol-Myers Squibb (BMY) stake by 7.7% in Q1 2026, buying an estimated $10.7M and bringing the position to 2,561,350 shares worth $155M. The position accounts for 0.07% of the portfolio, ranked #270.
Citigroup first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $462M in Q4 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Citigroup held 2,561,350 shares of Bristol-Myers Squibb worth $155M as of Q1 2026.
- Citigroup bought 183,928 Bristol-Myers Squibb shares in Q1 2026, an estimated $10.7M.
- Bristol-Myers Squibb made up 0.07% of Citigroup's portfolio in Q1 2026, its #270 holding.
- Citigroup first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Citigroup's Bristol-Myers Squibb position peaked at $462M in Q4 2022.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.